Cargando…
A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis
The outcome of intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) is only favorable in ≈ 40% of acute ischemic stroke (AIS) patients. Moreover, in ≈ 6–8% of cases, intracerebral hemorrhage (ICH) develops. We tested whether a modification of clot lysis assay (CLA), might...
Autores principales: | Orbán-Kálmándi, Rita, Szegedi, István, Sarkady, Ferenc, Fekete, István, Fekete, Klára, Vasas, Nikolett, Berényi, Ervin, Csiba, László, Bagoly, Zsuzsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208992/ https://www.ncbi.nlm.nih.gov/pubmed/34135389 http://dx.doi.org/10.1038/s41598-021-92041-1 |
Ejemplares similares
-
Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis
por: Szegedi, István, et al.
Publicado: (2021) -
A Modified in vitro Clot Lysis Assay Predicts Outcomes in Non-traumatic Intracerebral Hemorrhage Stroke Patients—The IRONHEART Study
por: Orbán-Kálmándi, Rita, et al.
Publicado: (2021) -
Low α2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis
por: Székely, Edina Gabriella, et al.
Publicado: (2022) -
High Neutrophil–Lymphocyte Ratio and Low Lymphocyte–Monocyte Ratio Combination after Thrombolysis Is a Potential Predictor of Poor Functional Outcome of Acute Ischemic Stroke
por: Sadeghi, Farzaneh, et al.
Publicado: (2022) -
Elevated Factor VIII and von Willebrand Factor Levels Predict Unfavorable Outcome in Stroke Patients Treated with Intravenous Thrombolysis
por: Tóth, Noémi Klára, et al.
Publicado: (2018)